NextCure Statistics
Total Valuation
NextCure has a market cap or net worth of $38.88 million. The enterprise value is -$44.62 million.
Important Dates
The next estimated earnings date is Thursday, October 31, 2024, after market close.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NextCure has 27.98 million shares outstanding. The number of shares has increased by 0.44% in one year.
| Shares Outstanding | 27.98M |
| Shares Change (YoY) | +0.44% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 1.81% |
| Owned by Institutions (%) | 33.02% |
| Float | 18.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.35, with a Debt / Equity ratio of 0.07.
| Current Ratio | 8.35 |
| Quick Ratio | 8.03 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.74% and return on invested capital (ROIC) is -33.57%.
| Return on Equity (ROE) | -54.74% |
| Return on Assets (ROA) | -31.09% |
| Return on Capital (ROIC) | -33.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$747,305 |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.34% in the last 52 weeks. The beta is 0.78, so NextCure's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +5.34% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 1.52 |
| Relative Strength Index (RSI) | 48.96 |
| Average Volume (20 Days) | 38,758 |
Short Selling Information
The latest short interest is 65,811, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 65,811 |
| Short Previous Month | 77,836 |
| Short % of Shares Out | 0.24% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 2.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -63.66M |
| Pretax Income | -61.28M |
| Net Income | -61.28M |
| EBITDA | -60.40M |
| EBIT | -63.66M |
| Earnings Per Share (EPS) | -$2.20 |
Full Income StatementBalance Sheet
The company has $86.44 million in cash and $6.29 million in debt, giving a net cash position of $80.15 million or $2.86 per share.
| Cash & Cash Equivalents | 86.44M |
| Total Debt | 6.29M |
| Net Cash | 80.15M |
| Net Cash Per Share | $2.86 |
| Equity (Book Value) | 85.44M |
| Book Value Per Share | 3.05 |
| Working Capital | 79.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$45.83 million and capital expenditures -$630,000, giving a free cash flow of -$46.46 million.
| Operating Cash Flow | -45.83M |
| Capital Expenditures | -630,000 |
| Free Cash Flow | -46.46M |
| FCF Per Share | -$1.66 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |